Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine

Cancer

Volumn 79, Issue 2, 1997, Pages 362-369

  Yoshida, Kazuhiro ^a   Sugino, Takashi ^a   Tahara, Hidetoshi ^c   Woodman, Anthony ^a   Bolodeoku, John ^a   Nargund, Vinod ^b   Fellows, Griff ^b   Goodison, Steven ^a   Tahara, Eiichi ^c   Tarin, David ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

bladder carcinoma; exfoliated cancer cells; noninvasive diagnosis; telomerase; urine

Indexed keywords

TELOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; URINALYSIS; URINE CYTOLOGY;

AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0031024372     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970115)79:2<362::AID-CNCR20>3.0.CO;2-Y     Document Type: Article

References (29)

1. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989;59:521-9.
2. Greider CW, Blackburn EH. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987;51:887-98.
3. Counter CM, Avilion AA, LeFeuvre CE, Atewart NG, Greider CW, Harley CB, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
4. Greider CW. Mammalian telomere dynamics: healing, fragmentation, shortening and stabilization. Curr Opin Genet Dev 1994;4:203-11.
5. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994;91:2900-4.
6. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995;87:884-94.
7. Shay JW, Werbin H, Wright WE. You haven't heard the end of it:telomere loss may link human aging with cancer. Can J Aging 1995;14:511-24.
8. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5.
9. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatysek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcome. Nature Med 1995;1:249-55.
10. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995;87:895-902.
11. Tahara H, Nakanishi T, Kitamoto M, Nakasho R, Shay JW, Tahara E, et al. Telomerase activity in human liver tissues:comparison between chronic liver disease and hepato-cellular carcinomas. Cancer Res 1995;55:2734-6.
12. Tahara H, Kuniyasu H, Yasui W, Yokozaki H, Shay JW, Ide T, et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995;1:1245-51.
13. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55:2533-6.
14. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-62.
15. Langford LA, Piatyszek MA, Xu R, Schold SC Jr., Shay JW. Telomerase activity in human brain tumours. Lancet 1995; 346:1267-8.
16. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995;23:3794-5.
17. Collins K, Kobayashi R, Greider CW. Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell 1995;81:677-86.
18. Flint J, Craddock CF, Villegas A, Bentley DP, Williams HJ, Galanello R, et al. Healing of broken human chromosomes by addition of telomeric repeats. Am I Hum Genet 1994; 55:505-12.
19. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, et al. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994;66:l-9.
20. Murnane JP, Sabatier L, Marder BA, Morgan WF. Telomere dynamics in an immortal human cell line. EMBO J 1994; 13:4953-62.
21. Koss LG, Deitch D, Ramamathan R, Sherman AB. Diagnostic value of cytology of voided urine. Acta Cytol 1985;29:810-6.
22. Meuleman EJH, Delaere KPJ. Diagnostic efficacy of the combination of urine cytology, urine analysis and history in the follow-up of bladder carcinoma. Br J Urol 1988;62:150-3.
23. Kern WH. The grade and pathologic stage of bladder cancer. Cancer 1984;53:1185-9.
24. Sidransky D, Eschenbach AV, Tsai YC, Jones P, Summerhayes I, Marshall F, et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 1991;252:706-9.
25. Haliassos A, Liloglou T, Likourinas M, Doumas C, Ricci N, Spandidos DA. H-ras oncogene mutations in the urine of patients with bladder tumours:description of a non-invasive method for the detection of neoplasia. Int J Oncol 1992;1:731-4.
26. Matsumura Y, Hanbury D, Smith J, Tarin D. Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. BMJ 1994;308:619-24.
27. Matsumura Y, Sugiyama M, Matsumura S, Hayle AJ, Robinson P, Smith JC, et al. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Pathol 1995;177:11-20.
28. Sugiyama M, Woodman A, Sugino T, Crowley S, Ho K, Smith J, et al. Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine. J Clin Pathol: Mol Pathol 1995;48:M142-7.
29. Mao L, Schoenberg MP, Scicchitano M, Erozan YS, Merlo A, Schwab D, et al. Molecular detection of primary bladder cancer by microsatellite analysis. Science 1996;271:659-62.